Sigurd D Süssmuth

5PUBLICATIONS
17CO-AUTHORS
Molecular medicineCharacterisation of biological macromoleculesPharmacogenomicsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 05, 2026
NMDA subunit 2B-selective negative allosteric modulator satoprodil (BI 1569912) as mono- and adjunctive therapy in patients with major depressive disorder: results from two phase 2 randomized, controlled trials.

|Sep 02, 2026
Safety, tolerability and pharmacokinetics of an NMDA receptor subunit 2B-selective negative allosteric modulator, BI 1569912: Results of three partially randomised, placebo-controlled phase I trials.

|Aug 14, 2026
Dopaminergic modulation of social reward anticipation in depression: neural effects of amisulpride versus placebo.

|Jun 25, 2026
Investigating the effect of increased dopamine signaling on cerebral blood flow in Major Depressive Disorder: a double-blind randomized placebo-controlled study.

|Dec 23, 2024
Safety of BI 1358894 in patients with major depressive disorder: Results and learnings from a phase II randomized decentralized clinical trial.

Christopher Reist, Peide Li, Thuy Le Nguyen

Pageof 1

Frequent Collaborators

2 joint publications

Matti Gärtner

2 joint publications

Marvin S Meiering

2 joint publications

Moritz Hempel

2 joint publications

Rebecca Gruzman